[HTML][HTML] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological research, 2021 - Elsevier
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation.
G Reyes-Soffer, M Westerterp - Pharmacological Research, 2021 - europepmc.org
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological …, 2021 - pubmed.ncbi.nlm.nih.gov
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological research, 2021 - research.rug.nl
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
[HTML][HTML] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological research, 2021 - ncbi.nlm.nih.gov
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
[PDF][PDF] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological Research, 2021 - core.ac.uk
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
[PDF][PDF] Beyond Lipoprotein (a) plasma measurements: Lipoprotein (a) and inflammation
G Reyes-Soffer, M Westerterp - Pharmacological Research, 2021 - core.ac.uk
Genome wide association, epidemiological, and clinical studies have established high
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …
lipoprotein (a)[Lp (a)] as a causal risk factor for atherosclerotic cardiovascular disease …